特拉华州威尔明顿的。，March 8, 2021 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors approved a new $1.5 billion share buyback program which expires on June 30, 2022 ("2021 Share Buyback Program"). Under the 2021 Share Buyback Program, shares of the Company's common stock may be repurchased periodically in open market or privately negotiated transactions. The actual timing, manner, number, and value of shares repurchased under the program will be determined by management at its discretion and will depend on a number of factors, including the market price of DuPont's common stock, general market and economic conditions, applicable requirements, and other business considerations.
截至2020年12月31日，根据现有股票回购计划(“2019股票回购计划”)，公司拥有回购约10亿美元公司普通股的剩余授权。正如在2021年2月9日的2020年第四季度收益电话会议上所讨论的，公司已根据2019年股票回购计划恢复股票回购，并打算在2019年6月1日股票回购计划到期之前完成剩余的10亿美元股票回购。在2019年股票回购计划完成后，公司预计将根据2021年股票回购计划回购股票，具体取决于管理层的酌情决定权和上述讨论的因素。
对杜邦公司
杜邦公司(NYSE: DD)是全球创新领导者，以技术为基础的材料和解决方案帮助改变行业和日常生活。我们的员工运用不同的科学和专业知识，帮助客户在电子、交通、建筑、水、医疗和工人安全等关键市场推进他们的最佳理念，并提供必要的创新。有关该公司、其业务和解决方案的更多信息，请访问www.lufeng-fst.com．投资者可访问网站投资者关系部分的信息，网址为investors.dupont.com．
关于前瞻性陈述的警告声明
本函件包含联邦证券法所指的“前瞻性陈述”，包括经修订的《1933年证券法》第27A节和经修订的《1934年证券交易法》第21E节。在这种情况下，前瞻性陈述通常涉及预期的未来业务、财务业绩和财务状况，并经常包含诸如“期望”、“预期”、“打算”、“计划”、“相信”、“寻求”、“看到”、“将”、“将”、“目标”等词，以及这些词的类似表达和变体或否定形式。
2019年4月1日，本公司通过Dow Inc的分拆完成了材料科学业务的分离，（“Dow”），包括Dow化学公司（“Dow分布”）。On June 1, 2019, the Company completed the separation of the agriculture business through the spin-off of Corteva, Inc. ("Corteva") including Corteva's subsidiary E. I. du Pont de Nemours and Company ("EID"), (the "Corteva Distribution and together with the Dow Distribution, the "DWDP Distributions").
在2021年2月1日，公司通过反向莫里斯信托交易(“N&B交易”)将营养与生物科学(“N&B”)业务剥离给国际香料香料公司(“IFF”)，导致IFF向杜邦股东发行股票。
2021年3月8日，杜邦宣布进入最终协议，以获得莱尔德绩效材料业务，须经监管批准和习惯性关闭条件（“提议的莱尔德PM收购”）。
前瞻性陈述涉及到不同程度，不确定，并且受风险，不确定性和假设的重要事项，其中许多超出了杜邦的控制，这可能导致实际结果与任何前瞻性陈述中表达的结果不同。前瞻性陈述不保证未来结果。可能导致杜邦的实际结果与任何此类前瞻性陈述中预测的实际结果不同的一些重要因素包括但不限于：（i）能够达到关于时间，完成，集成和会计的期望和与拟议的Laird PM收购有关的税务处理;（ii）在预期的时间框架内或全部或成功整合莱尔德绩效材料业务的建议莱尔德PM收购，实现预期利益，协同效应和经营效率的能力;（iii）能够实现与N＆B交易或DWDP分配有关的预期税收处理;（iv）相关税和其他法律的变化;（v）与Corteva分配有关EID的某些遗产负债的赔偿;（vi）与杜邦，Corteva和Chemours公司与未来合格的PFAS费用相关的成本分摊和Chemours公司之间的绩效和影响有关的风险和成本;（vii）未能有效管理收购，剥夺，联盟，合资企业和其他组合变更，包括与Corteva发行方式与Corteva发行有关的信函协议的会议条件，与某些资产和企业转移有关; (viii) uncertainty as to the long-term value of DuPont common stock; (ix) risks and uncertainties related to the novel coronavirus (COVID-19) and the responses thereto (such as voluntary and in some cases, mandatory quarantines as well as shut downs and other restrictions on travel and commercial, social and other activities) on DuPont's business, results of operations, access to sources of liquidity and financial condition which depend on highly uncertain and unpredictable future developments, including, but not limited to, the duration and spread of the COVID-19 outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions resume; and (x) other risks to DuPont's business, operations; each as further discussed in detail in and results of operations as discussed in DuPont's annual report on Form 10-K for the year ended December 31, 2020 and its reports on Form 10-Q and Form 8-K. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
除非另有说明，杜邦™、杜邦椭圆形徽标以及所有标有™、SM或®的商标和服务标记均由杜邦de Nemours, Inc.的附属公司拥有。
欲了解更多信息，请联系:
杜邦公司投资者关系
李兰韦弗
302-999-2477
(电子邮件保护)
杜邦媒体关系
丹•特纳
302-299-7628
(电子邮件保护)
投资者关系:
消息(传输代理)
+ 1-866-644-4129(免费;仅限美国+加拿大)
+ 1 201-680-6578(人数;美国和加拿大以外)
+1 800-231-5469(听力受损)
杜邦公司投资者关系:
+ 1 302-774-3034
查看原始内容以下载多媒体：http://www.prnewswire.com/news-releases/dupont-announces-board-approval-of-1-5-billion-share-buyback-program-301242056.html
源杜邦